Background and Purpose-Stroke rates are higher in men compared with women in the fourth through seventh decades of life, and higher rates may result from differences in carotid intraplaque hemorrhage (IPH), an unstable atherosclerotic plaque component. We report age-specific sex differences in the presence of magnetic resonance imaging-depicted carotid IPH. 
S
troke incidence is lower in women compared with men between the ages of 45 and 74 years.
1,2 The difference in stroke incidence, however, is eliminated after 75 years of age. 1, 2 The protection from stroke conferred on women between the ages of 45 and 74 years may be related to the protective effects of pre-menopausal sex hormones that delay the onset of atherosclerosis. 3, 4 Women have been reported to have less plaque burden and more stenosis compared with men, 5 suggesting that sex hormones play a role in arterial remodeling. Data on the age-specific sex differences in carotid plaque components and their natural course are sparse.
Pathology and imaging studies have reported carotid atherosclerosis composition differences between the sexes. 6, 7 One specific plaque component, intraplaque hemorrhage (IPH), is a biomarker of plaque instabilty associated with the progression of atherosclerosis, 8 a high-risk cardiovascular phenotype, 9, 10 and future cerebrovascular outcomes, including stroke. [11] [12] [13] [14] Several recent studies point to IPH as a potential source of thromboembolism among patients with embolic stroke of undetermined source, which by definition have nonstenotic carotid artery disease (<50%). 15, 16 Studies are needed understand the determinants of IPH in low-grade (<50%) carotid stenosis, and data on the age-specific sex differences in carotid plaque components and their natural course are sparse in these patients. Furthermore, prior studies have demonstrated that male sex and age are associated with the presence of IPH 6, 7, 17 ; however, whether sex modifies the effect of age remains to be investigated.
Magnetic resonance imaging (MRI) can identify carotid IPH. [18] [19] [20] [21] Validated carotid IPH pulse sequences, such as 3-dimensional (3D) T1-weighted gradient echo (GRE), 18, 22, 23 may be implemented into routine clinical protocols.
22 3D T1-weighted GRE is routinely combined with magnetic resonance angiography at our institution providing an opportunity to study the IPH biomarker in a large clinical population.
The objective of this study was to report age-specific sex differences in MRI-depicted carotid IPH in an institutional sample comprising 10 years of data. Given that age-specific stroke rates are lower in women between ages 45 and 74 compared with men, carotid artery disease is a major cause of stroke, and women may have greater proportions of stable plaque components, we hypothesized that age-specific sex
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August 2017 differences in carotid IPH exist to help explain previously reported differences in stroke rates. Specifically, we hypothesized that men have greater age-specific odds of MRIdepicted carotid IPH compared with women and that with increasing age, the odds of carotid IPH in women becomes closer to that of men. We report age-specific sex differences in the presence of MRI-depicted carotid IPH in patients with <50% stenosis.
Methods
Institutional ethics board approval was received for this study, and the requirement for informed consent was waived.
Participants and Study Groups
Patients (n=1115) referred for neurovascular MRI undergoing 3D T1-weighted GRE black-blood imaging for the presence of carotid IPH between 2005 and 2014 were considered for study inclusion. Study exclusion criteria included (1) carotid artery disease ≥50% stenosis to exclude patients with higher plaque volumes given that plaque volume and stenosis are positively correlated, 24 and (2) patients with prior carotid endarterectomy because plaque components may have been altered as a result of iatrogenic causes.
Age groups were defined a priori as <45, 45 to 54, 55 to 64, 65 to 74, and ≥75 years paralleling studies of age-specific sex differences in stroke, such as the Greater Cincinnati/Northern Kentucky Stroke Study. 2, 25 Patients undergoing neurovascular MRI, including 3D T1-weighted GRE imaging, at our institution in this study included suspected neurovascular disease patients (usually symptomatic) referred by physicians, including stroke neurologists for neurovascular evaluation.
Carotid MRI Protocols
3D T1-weighted GRE imaging allows for the identification of carotid IPH. 18, 19 This acquisition exploits the T1-shortening effects of methemoglobin resulting in high signal intensity that indicates the presence of carotid IPH (see Figures 1 and 2 ).
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3D T1-weighted GRE imaging was performed on a Philips Medical System Scanner with a 16 channel neurovascular coil using a T1-weighted fat-saturated (using a selected water excitation radiofrequency pulse) fast-field echo sequence, with imaging acquired in the coronal plane (repetition time, 11 ms; echo time, 4 ms; field of view, 270×190 mm 2 ; matrix, 512×256 mm 2 ; slices, 100; throughplane thickness, 0.5 mm; voxel size, 0.5×0.7×0.5 mm 3 ) interpolated. Imaging was also performed on a GE 1.5 Tesla MR (Twinspeed) with an 8-channel neurovascular phased-array coil (USA Instruments, Aurora, OH) using a T1-weighted fat-saturated (Special [spectral inversion at lipids]; GE Healthcare) GRE sequence (repetition time, 6.7 ms; echo time, 1.7 ms; flip angle, 15°; field of view, 300 mm 2 ; matrix size, 320×320; through-plane thickness, 2 mm; pixel size, 0.94×0.94×1 mm 3 ). 3D T1-weighted GRE imaging is robust, vendor agnostic, and similar IPH characteristics have been demonstrated at both 3T and 1.5T field strengths.
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Carotid IPH Imaging Analysis and Reliability
Carotid IPH is defined as plaque signal intensity that exceeds the intensity of the adjacent sternocleidomastoid by 50%. 9, [28] [29] [30] [31] Because patients at our institution underwent imaging with neurovascular rather than surface coils, issues of coil sensitivity related to magnetic field inhomogeneity were not an issue. Experienced neuroradiologists (range of experience, 15-40 years) and a cardiothoracic radiologist with subspecialty and academic expertise in vascular biology imaging (A.R.M., experience, 27 years) routinely report the presence of IPH on the clinically acquired 3D T1-weighted GRE imaging acquisition. Increased signal intensity was considered to be carotid IPH if it was in the carotid artery wall. The dichotomous interpretation of carotid IPH has well-established reliability, 27, 32 and κ coefficients are 0.75 and 0.9 for inter-and intraobserver reliability. 18 Concordance of clinical reports and an independent rater (rater NS; n=50) for carotid IPH was found to have a κ of 0.902 (95% confidence interval [CI], 0.769-1.000; SE, 0.068).
Clinical Records Review
Data collection included abstraction of data from neurovascular MRI reports and patients' charts using available physician consultation letters. Patients' electronic and paper charts were reviewed for cardiovascular risk factors, medication history, and atherosclerotic endorgan events, including history of transient ischemic stroke, stroke, and myocardial infarction. Traditional cardiovascular risk factors were included because they are independently associated with cardiovascular outcomes and therefore confound the evaluation of the effect of age and sex on the presence of carotid IPH.
Statistical Analysis
Continuous variables with a normal distribution were expressed as a mean and accompanied by an SD. Comparisons of age between men and women were made using an unpaired 2-sided t test. Pooled rather than Satterthwaite P values were reported because equal variances could be assumed. Categorical variables were reported as counts and percentages and were compared between the sexes using a 2-sided χ 2 test. Comparisons of binary matched data for differences in carotid IPH in the right versus left carotid arteries were made using a 2-sided McNemar test.
Logistic regression was used to evaluate the relationship of sex and carotid IPH. Multivariable logistic regression covariates included hypertension, dyslipidemia, diabetes mellitus type 2, and smoking history. To evaluate age-specific sex differences in carotid IPH, we included an age-by-sex covariate interaction term in reference and adjusted models. Statistical analysis was performed using SAS version 9.4 (SAS Institute, Cary, NC). A P<0.05 indicated a statistically significant difference. 
Results
Nine hundred and six patients (mean age±SD in years, 66.98±15.15) were eligible for study (see Figure 3) . Carotid IPH was found in 63 (6.95%) of included patients. Demographic, clinical characteristics, and carotid IPH presence are summarized in Table 1 . Men had greater proportions of hypertension, dyslipidemia, type 2 diabetes mellitus, and smoking history.
In men and women, carotid IPH was present in 11.43% (48 of 420) and 3.09% (15 of 486), respectively (P<0.0001). Figure 4 depicts the proportion of patients with carotid IPH stratified by sex and age. No patients had carotid IPH under the age of 45 years. Between ages 45 and 54 years, only 2 men had carotid IPH. Women <65 years of age were not found to have carotid IPH. The odds of carotid IPH was greater with age in both men and women, and the effect of carotid IPH on age was modified by sex in both univariable (β=0.075; SE=0.0352; P=0.0312) and multivariable (β=0.0737; SE=0.0361; P=0.0411) logistic regression. The odds of IPH among women converged with that of men with age as shown in the unadjusted and adjusted odds of age-specific sex differences in carotid IPH reported in Table 2 .
Bilateral carotid IPH was found in 9 of 420 (2.14%) men and 2 of 486 (0.41%) women and significantly differed between the sexes (P=0.0287). Men in the older age categories had higher proportions of bilateral IPH (see Table 2 ).
Of the 52 patients with only unilateral carotid IPH, 32 (61.54%) and 20 (38.46%) patients had an affected left and right side, respectively (P<0.0001). In these patients with unilateral disease, the left side was affected in 53.85% (7 of 13) of women (P=0.0006) and 64.10% (25 of 39) men (P<0.0001).
Discussion Findings
The data in this single institution study revealed that in patients with low-grade carotid artery stenosis, carotid IPH 
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occurs after the age of 45 years, is present in <1% of patients before the age of 55 years, and by the age of 75 years, affects as many as 12% of all patients. Women were not affected by carotid IPH before the age of 65 years. Moreover, men have greater odds of carotid IPH compared with women, and with increasing age post-menopause, the odds of carotid IPH in women also increases and becomes closer to that of men. In other words, sex modifies the effect of age on carotid IPH. To our knowledge, no other studies have investigated or demonstrated the convergence of risk of carotid IPH between the sexes with increasing age. The infrequency of carotid IPH, an unstable plaque component associated with future stroke, in women before the age of 75 years may in part explain the reason that women are relatively protected from stroke compared with men before the seventh decade of life. Our findings additionally suggest a delayed onset of carotid IPH in women.
Novelty
This study comprising ≈10 years of data, as a result of institutional incorporation of 3D T1-weighted carotid MRI into routine neurovascular imaging, provided an opportunity to test our hypothesis that carotid IPH exhibits age-specific sex differences. Thus, an opportunity was afforded to evaluate the age-specific sex differences in a large group of patients without significant carotid artery stenosis or higher pre-test probabilities of vessel wall disease. The use of a large homogenous group of low vessel wall volume disease patients reduces confounding factors in evaluating the relationship of age and sex that might be associated with higher grade disease, such as lifestyle differences. Because only a few minutes additional scan time is necessary to evaluate for IPH within existing neurovascular MRI protocols, it was possible to capture a relatively large data set of patients with low-grade carotid stenosis with information on their IPH status.
Other Studies
Observational and population studies, including MRI of plaque components, have found that age and sex are determinants of carotid IPH. 7, 33 Overall, our data found carotid IPH in 11% and 3% of men and women, respectively. Ota et al 7 found a prevalence of 24% and 6%. The higher prevalence of carotid IPH in the latter study may be attributed to Ota using an overall higher risk group, low-grade carotid stenosis arteries of patients with contralateral moderate-to-high grade carotid stenosis. In our study, the carotid IPH status in patients with bilateral low-grade stenosis was captured by incorporating carotid IPH imaging into routine clinical neurovascular MRI. This is in contrast to other studies and trials that select patients for vessel wall imaging as a result of their carotid stenosis 7 or intima-media thickness. In our study, men had 4.1 (95% CI, 2.2-7.4) greater odds of carotid IPH compared with women, which is similar to some reports. 7 Although our CIs overlap, our point estimate is higher compared with a population-based study reporting that plaques from men had a 2.2 (95% CI, 1.7-2.9) greater odds of IPH compared with women. 17 One reason for the difference in our study may be that, among the patients referred for neurovascular MRI and selected for <50% stenosis, rather than known carotid artery disease, a greater proportion of women may have been referred for MRI for neurovascular symptoms ultimately unrelated to carotid artery disease.
Men and women also had a slightly greater and statistically significant prevalence of carotid IPH within the left carotid artery. Ischemic stroke is more often diagnosed in the left hemisphere, 34 and the underlying cause of this discrepancy is unclear. This predilection may in theory be because of differences in shear stress resulting from anatomic differences between the left and right carotid arteries and plaque components. Although the increased diagnosis of stroke in the left hemisphere may be related to the underdiagnoses of right hemisphere stroke in clinical practice, 35, 36 the possibility of differences in plaque components and hemodynamic differences remains to be rigorously studied. Recently, differences in plaque components have been described, and our findings of sidedness are in line with these. 37 Together, the findings of sidedness and lack of symmetry in carotid IPH between the carotid arteries suggest that both local and systemic factors play a role in the development of carotid IPH.
Strengths
The strengths of the present study included the power to ascertain age-specific differences in carotid IPH with MRI using data acquired in the routine clinical setting that allowed us to capture a large data set of patients with bilateral low-grade carotid stenosis. The benefit of extracting our study sample from a clinical setting allows both potential application of any results to the clinical population of the sample studied (ie, external validity), as well as the ability to apply strict inclusion and exclusion criteria to ensure sufficient homogeneity allowing for greater internal validity. In addition to being rapid, the 3D T1-weighted GRE acquisition used is scanner agnostic and multivendor for the diagnosis of carotid IPH. The acquisition can also be incorporated into routine clinical protocols 22 as demonstrated in the group within this study. We chose to use this particular pulse sequence because it does not require surface coils and has been validated using neurovascular coils that are routinely available in the clinical setting. 18 The IPH biomarker is also detectable with other validated MRI acquisitions.
Limitations
This study had several limitations. First, the study was crosssectional and retrospective rather than longitudinal and prospective. Serial imaging studies are required to further understand the natural history of carotid atherosclerosis and provide deeper insights into the natural course of IPH. Such trials are underway, and their results are anticipated. 38 Serial imaging studies involving advanced imaging are costly, and this study exploited an opportunity to collect a large set of data in the course of routine clinical practice. While understanding the incidence of disease would require cohort studies, crosssectional studies cost effectively provide information on prevalence of disease. Second, information on age at menopause and menarche, parity, and use of hormone replacement therapy were not consistently available from charts. In developed countries, the average age of natural menopause of 51 years is used as a reference in cardiovascular studies, 39 and we interpreted our data with this knowledge. Third, although we were able to restrict our analysis to patients with <50% stenosis to exclude patients with higher plaque volumes given the correlation of stenosis with plaque volume, 24 our analyses were not adjusted for degree of stenosis. Finally, we did not evaluate plaque components, such as lipid core, fibrous cap or calcium, and any age-specific sex differences they may exhibit. Carotid IPH is emerging as a critically important plaque component in 
Future Studies
Differences in sex steroids may explain the observations in this study, including the lower odds of carotid IPH in women per decade of life, the delayed onset of IPH in women, and convergent risk between men and women with increasing age. Estrogen is known to play a role in the age-specific sex differences in cardiovascular disease and the 10-to 15-year delayed onset of coronary disease in women. 3, 4 Histopathology studies of the coronaries have demonstrated that post-menopausal women are at an increased risk of plaque rupture. 40 Carotid endarterectomy specimen studies have shown that plaques obtained from women are less inflammatory with lower macrophage and interleukin-8 content and with greater smooth muscle and collagen. 41 Plaque stabilization may be achieved via anti-inflammatory effects of estrogen modulated by its antioxidant and antiapoptosis effects. 42 Furthermore, estrogen may confer protection against atherosclerosis via several mechanisms, including the promotion of endothelial-mediated dilation and blood flow and cerebrovascular reactivity. Nitric oxide synthase and nitric oxide generation are increased by estrogen and may explain in part the protective role of estrogen in atherosclerosis. 42 Although the effects of estrogen on IPH require further investigation, estrogen's ability to attenuate the inflammatory processes that have been implicated in IPH suggests that sex steroid differences may account for some differences in carotid IPH presence.
The potential of menopause hormone therapy providing cardiovascular benefits remains unproven 43 although recent investigations demonstrate that timing of hormone therapy administration is critical to appreciate cardiovascular protection benefits. Post-menopausal administration of estradiol within 6 years of menopause onset may reduce progression of carotid intima-media thickness, 44 a marker of atherosclerosis that is strongly associated with cardiovascular outcomes. The relationship of post-menopause hormone therapy with plaque components using well-designed trials seems to be an avenue for future investigation.
Our results suggest that future cohort studies may be warranted to understand the role of carotid IPH and age-specific stroke rates, as well as further investigate the possibility of delayed incidence of carotid IPH in women. Prospective longitudinal studies to evaluate carotid IPH incidence rates in men and women would also clarify the natural history of carotid IPH and affirm the role of estrogen in sex differences.
Conclusions
Men have greater age-specific odds of MRI-depicted carotid IPH compared with women, and with increasing age, the odds of carotid IPH in women becomes closer to that of men. Differences in the presence of carotid IPH, an unstable plaque component, may partly explain differential stroke rates between the sexes, and further studies are warranted. 
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